Your browser doesn't support javascript.
loading
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Ho, Diep; Huang, Jessica; Chapman, Judith-Anne W; Leitzel, Kim; Ali, Suhail M; Shepherd, Lois; Parulekar, Wendy R; Ellis, Catherine E; Crescnzo, Rocco J; Zhu, Liting; Virk, Shakeel; Nomikos, Dora; Aparicio, Samuel; Gelmon, Karen A; Carney, Walter P; Lipton, Allan.
Afiliação
  • Ho D; Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA.
  • Huang J; Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA.
  • Chapman JW; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Leitzel K; Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA.
  • Ali SM; Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA.
  • Shepherd L; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Parulekar WR; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Ellis CE; Oncology, GlaxoSmithKline, Collegeville, PA, USA.
  • Crescnzo RJ; Oncology, GlaxoSmithKline, Collegeville, PA, USA.
  • Zhu L; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Virk S; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Nomikos D; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Aparicio S; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Gelmon KA; British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Carney WP; Walt Carney Biomarkers Consulting, LLC Cambridge, Boston, MA, USA.
  • Lipton A; Penn State Hershey Medical Center, Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA, 17033, USA. alipton@hmc.psu.edu.
Breast Cancer Res Treat ; 164(3): 571-580, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28484925
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias da Mama / Receptor ErbB-2 / Inibidor Tecidual de Metaloproteinase-1 / Trastuzumab / Anidrase Carbônica IX / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias da Mama / Receptor ErbB-2 / Inibidor Tecidual de Metaloproteinase-1 / Trastuzumab / Anidrase Carbônica IX / Antígenos de Neoplasias Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos